Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-held and emerging growth companies in the Health Sciences, Biotech and Technology industries.
Ramko has extensive experience serving large, publicly-held companies as well as newly formed start-ups and venture-backed enterprises. Richard has 15 years of experience, including 13 years in public accounting and 2 years in executive level financial positions in private industry and is a certified public accountant in Florida and Tennessee. Some of his current clients include Andrx Corporation, Nabi Biopharmaceuticals, Stiefel Laboratories and SFBC International.
Once again in 2005, large pharma and biotech companies increased their appetite for partnerships and alliances to fuel early stage and late stage pipeline requirements. Overall, mid and late stage deals extended the trend of the last few years representing about half of all biotech out-licensing de...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
